O-Linked N-acetylglucosamine (O-GlcNAc), a single GlcNAc modification of proteins, is abundant in nucleocytoplasmic proteins of eukaryotes. Most nuclear transcriptional regulator proteins carry O-GlcNAc, implicating O-GlcNAc in gene regulation. This study suggested the possibility that O-GlcNAc regulates cooperative binding of Sp1 and its collaborating transcription factors, Oct1 and Elf-1, onto DNA templates in vivo. Chromatin immunoprecipitation assays on cells in which O-GlcNAc was modulated pharmacologically revealed that Sp1-Oct1-and Sp1-Elf-1-paired occupancies of previously known target promoter regions were suppressed by elevated O-GlcNAc modification. Since these pairs of transcription factors bind the target promoters cooperatively and DNA binding of Sp1 alone is not affected by O-GlcNAc, our results imply that O-GlcNAc weakens the DNA binding of Sp1 and its cooperative binding partners by inhibiting stable interaction on DNA templates.
O-Linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of serine and threonine residues of proteins by single N-acetylglucosamine (GlcNAc).
1) O-GlcNAc is strikingly different from traditional protein glycosylations in several respects. It is not elongated, is localized in the nucleocytoplasm, unlike glycoproteins which are localized in secretory pathways, and is extensively involved in cell regulation. 1, 2) Reversible modification of proteins by O-GlcNAc is mediated by O-GlcNAc transferase (OGT), which attaches GlcNAc to the hydroxyl groups of serine and threonine residues, and O-GlcNAcase (OGA), which removes GlcNAc from proteins. 1) Since the discovery of OGlcNAc, hundreds of nucleocytoplasmic proteins have been identified as O-GlcNAcylated, including transcriptional regulatory proteins and signaling mediators. 1, 3, 4) Deregulation of O-GlcNAc metabolism is intimately connected to human disease. 5, 6) Especially, altered OGlcNAc levels perturb insulin signaling and contribute to the development of diabetes and diabetic complications. 4, 7) Increased O-GlcNAc modification enhances cellular tolerance to stress and cell survival. [8] [9] [10] OGlcNAc interplays with serine/threonine phosphorylation (O-phosphorylation). 5, 11) O-GlcNAcylation of transcription factors regulates their stability and activity, thereby affecting gene expression. [12] [13] [14] [15] Sp1 regulates the transcription of various genes, and its activity is controlled by post-translational modifications, including phosphorylation and O-GlcNAcylation. 16) It is well-established that Sp1 activates gene transcription cooperatively with various other transcription factors. 16) Human U2 snRNA promoter contains a GC:Octa element (À232 to À207), composed of a Sp1 binding motif (GC box) and an Oct1 binding motif (Octa). Sp1 activates this element through cooperation with Oct1 for efficient transcription of the U2 snRNA gene. 17, 18) The rat placenta and embryonic expression oncofetal protein gene (Pem) promoter contains a Pd element (À101 to À79), in which one GC box and two Ets factor-binding sequences are located adjacent to one another. Sp1 activates this element cooperatively together with Ets factors, including Elf-1. 19) Recent studies have revealed important aspects of O-GlcNAc regulation of gene expression. Sp1 OGlcNAcylation inhibits Sp1-involved transcription activation, possibly by interrupting cooperative interactions with other transcription regulators, such as dTAFII110, Oct1, Elf-1, and SREBP2. [20] [21] [22] [23] O-GlcNAc also interrupts CREB-TAFII130 interaction and NFB-IB association. 14, 24) Importantly, O-GlcNAc is dynamically engaged in transcription processes in the context of chromatin. 15, 25) Here we present the first in vivo evidence confirming that O-GlcNAc modulates interactions of transcription regulators with DNA templates.
Materials and Methods
Materials. Streptozotocin (STZ) was purchased from SigmaAldrich (St. Louis, MO). Antibodies to Sp1, Oct1, Elf-1, and actin were from Santa Cruz Biotechnology (Santa Cruz, CA). Antibody to O-GlcNAc (CTD110.6) was from Covance (Province, NJ).
Cell culture. Human hepatoma Huh7 and rat neuroblastoma B103 cells were maintained in Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum.
Plasmids and transfection. The construction of plasmids was described previously. 21, 22) Transfection was performed using polyethyleneimine (PEI; Sigma-Aldrich). Plasmid DNA and 30 mM PEI solution were mixed in a ratio of 1:3.5 (mg:ml). After 20 min, DNA-PEI mixture was added to the cells, and incubation continued for 36 h to 42 h.
y To whom correspondence should be addressed. Tel: +82-2-3290-3421; Fax: +82-2-923-9923; E-mail: hichang@korea.ac.kr Luciferase reporter assay. Luciferase reporter assays were performed as previously described. 21) Briefly, cells in 12-well dishes were transfected with the indicated plasmids along with pCMV--galactosidase as internal control. Luciferase activities were normalized by -galactosidase activities, and the mean AE SD from triplicate assays is presented.
Immunoblotting and immunoprecipitation. Immunoblotting and immunoprecipitation were performed as previously described. 21, 22) Coimmunoprecipitation (CoIP). Huh7 and B103 cells were washed with phosphate buffered saline (PBS) and incubated with 0.5-1 mM dithiobis[succinimidylpropionate] (DSP; Pierce, Rockford, IL) for 30 min. DSP is a cell-permeable protein crosslinker that is cleavable by reducing reagents. 21) After DSP was quenched with 50 mM Trisbuffered saline for 10 min, cell lysate was prepared in RIPA (20 mM sodium phosphate, pH 7.4, 300 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 10% glycerol) supplemented with protease inhibitors and 50 mM GlcNAc. Immunoprecipitation was performed using the indicated antibodies and ExtraCruz IP reagent (Santa Cruz Biotechnology).
Chromatin immunoprecipitation (ChIP). ChIP assays were performed following the ChIP protocol provided by Millipore Corporation (Billerica, MA). Briefly, cells on a 100 mm-diameter dish were crosslinked with 1% formaldehyde and lysed in 0.6% SDS-containing lysis buffer. The liberated chromatin was sheared by sonication and spun for clarification. The cleared lysate (0.6 ml) was divided among three tubes (0.2 ml) and diluted to reduce the SDS concentration below 0.1%. Each of the diluted lysates was incubated with 1 mg of the indicated antibodies overnight, and then with 20 ml of preblocked protein G-agarose (Santa Cruz Biotechnology) for 4 h. Input samples (1% of the clarified lysates after sonication) and immunoprecipitated fractions were reversed and purified. The presence of DNA fragments containing the target promoter region was revealed by PCR using the following primers: Pem Pd (
0 and R 5 0 -CGCAGGTGCT-ACCGTCTCTCACCTC-3 0 ). Quantitative PCR (qPCR) was performed using Lightcycler 480 (Roche, Basel, Switzerland) and the KAPA SYBR FAST qPCR master mix (KAPA Biosystems, Boston, MA). The levels of the target region in the immunoprecipitated fractions were normalized against those in the input samples (mean AE SD for six to nine independent samples) and expressed as fold change of those from the untreated and control cells.
Results

Streptozotocin (STZ)
, which is widely used to induce diabetes-like symptoms in animal models, inactivates OGA, thus inhibiting O-GlcNAc turnover. 26, 27) Previous studies using STZ indicate that O-GlcNAc accumulation leads to alterations in cell physiology as well as the activity of specific proteins, including Sp1, p53, and NFB. [12] [13] [14] [28] [29] [30] Sp1 transcription factor interacts with Oct1 and Elf-1 for synergistic activation of transcription, but their interactions are interrupted by O-GlcNAc. 21, 22) To determine how STZ-induced O-GlcNAc elevation affects Sp1-Oct1 and Sp1-Elf-1 physical interactions, we performed CoIP assays on B103 rat neuroblastoma and Huh7 human hepatoma cells treated with 5 mM STZ or a vehicle (water). Immunoblot analysis of the immunoprecipitated fractions showed that STZ increased the O-GlcNAc levels of both Sp1 and Elf-1, but reduced coprecipitation of Sp1 and Elf-1, indicating that the O-GlcNAc state of these proteins is inversely related to their association in vivo (Fig. 1A) . Identically, we performed Sp1-Oct1 CoIP assays and detected lesser amounts of Oct1 in the Sp1-immunoprecipitated fraction of STZ-treated Huh7 cells than the untreated cells (Fig. 1B) . These results suggest that STZ-induced elevation of O-GlcNAc decreases Sp1 interaction with Elf-1 and Oct1.
Next we determined whether STZ would reduce transcription from the GC:Octa element of human U2 snRNA promoter and the Pd element of rat Pem promoter by luciferase reporter assays with reporter constructs, p(GC:Octa)-Luc and pPd-Luc, 21, 22) in which the GC:Octa and Pd elements drive luciferase gene transcription. These two promoter elements are cooperatively activated, by Sp1-Oct1 and Sp1-Elf-1 respectively. Huh7 and B103 cells were transfected with p(GC:Octa)-Luc and pPd-Luc, and further incubated with STZ. Consistently with the results shown in Fig. 1 , STZ elevated the O-GlcNAc levels of cellular proteins without noticeable changes in the protein levels of Sp1, Elf-1, or Oct1 ( Fig. 2A and B , right panels). However, STZ lowered the luciferase activities of both reporters ( Fig. 2A and B , left panels), suggesting that STZ-induced elevation of O-GlcNAc inhibits transcription from the promoter elements. These results are consistent with previous ones, that O-GlcNAc suppresses interaction between Sp1 and its collaborators, Oct1 and Elf-1. 21, 22) Therefore, in order to determine whether O-GlcNAc is capable of interrupting Sp1-Oct1 and Sp1-Elf-1 cooperative binding to DNA in vivo, we performed a series of ChIP on cells in which O-GlcNAc was modulated pharmacologically by STZ. Huh7 cells untreated and treated with STZ were crosslinked using formaldehyde, and sheared chromatins were prepared, followed by immunoprecipitation using Sp1 or Oct1 antibody. DNA fragments containing the target elements in the immunoprecipitated fractions were detected and quantified by real-time qPCR using primers encompassing the GC:Octa element. As shown in Fig. 3A , STZ reduced both the Sp1-and the Oct1-immunoprecipitation of GC:Octa element-containing DNA fragments, suggesting that Sp1 and Oct1 occupy the GC:Octa element less efficiently in STZ-treated cells than in untreated ones. Since the Sp1 and Oct1 levels were not reduced by STZ treatment ( Fig. 2A and B) , the lowered occupancy is not related to the possibility of STZ-induced variations in the Sp1 and Oct1 protein levels. The U2 snRNA-encoding gene and its surrounding regions contain multiple putative Sp1-binding GC boxes (Fig. 3B) . We examined the Sp1 occupancy of these GC boxes to determine whether STZ would also inhibit Sp1-binding to these regions, distant from the GC:Octa element. Sp1-immunoprecipitated fractions of Fig. 3A were used for qPCR to compare the Sp1 immunoprecipitation levels of the GC boxes located between þ158 and þ258 of the U2 snRNA gene from untreated cells and cells with STZ. As shown in Fig. 3B , STZ slightly decreased the Sp1 immunoprecipitation of these GC boxes, but this was much less noticeable than that of the GC:Octa element, despite the insufficient distance (approximately 400 bp) between the GC:Octa element and this region to exclude immunoprecipitation of each other fully. Combined with the previous observation that Sp1 O-GlcNAcylation does not affect DNA binding of Sp1 alone, 3) these results suggest that STZ-induced O-GlcNAcylation alters Sp1-Oct1 cooperative binding to the GC:Octa element rather than Sp1 DNA binding itself. A, Huh7 cells growing in 100-mm diameter dishes were treated with STZ as in Fig. 1 , and ChIP assays were performed, as described under ''Materials and Methods.'' The levels of U2 snRNA promoterderived DNA fragments immunoprecipitated by the indicated antibodies were measured by qPCR and normalized against those in the inputs. Data represent mean AE SD for nine immunoprecipitated samples (three samples for control IgG), and are expressed as fold change of those not treated with STZ. Amplified DNA from qPCR was determined by agarose gel electrophoresis (numbers indicate different samples). The nucleotide sequence around the amplified region of U2 snRNA promoter is shown. Arrows indicate sequences corresponding to the primers for PCR amplification. B, The levels of DNA fragments located between þ158 and þ248 from the U2 snRNA gene in the Sp1-immunoprecipitated fractions in Fig. 3A were detected and quantified by qPCR. Amplified DNA from qPCR was determined by agarose gel electrophoresis (numbers indicate different samples). The nucleotide sequence around the PCR amplified region is shown. Arrows indicate sequences annealed by the PCR primers. Myf3, myogenic regulatory factor 3. immunoprecipitated using Sp1 or Elf-1 antibody, and the levels of Pd-containing DNA fragments in the immunoprecipitated fractions were compared by qPCR. The results showed that STZ reduced Sp1-and Elf-1-binding to Pd (Fig. 4A and B) . In contrast, Sp1-binding to a GC box located in a remote region from Pd (approximately 1.5 kb distant) was not reduced but slightly increased by STZ (Fig. 4C) . Collectively, our results suggest that elevated O-GlcNAcylation suppresses Sp1 cooperative binding to DNA templates with its collaborators, Oct1 and Elf-1.
Discussion
In this study, we used STZ to alter cellular O-GlcNAc levels, and found that STZ reduced the interaction between the tested transcription factors not only in solution but at the level of DNA binding of the specific target promoter regions as well. Since STZ induces not only OGA inactivation but also other effects such as DNA alkylation, 31) it might cause an overall reduction of DNA binding of transcription factors. But this appears unlikely, at least as for Sp1, given that Sp1-binding to GC boxes distant from the target promoter regions, GC:Octa and Pd element, was not inhibited by STZ. A firm conclusion will be drawn after extensive examination of STZ-induced variable Sp1 occupancies of a larger number of promoters.
It is generally accepted that O-GlcNAc and serine/ threonine-O-phosphorylation interact with each other; O-GlcNAc and O-phosphate might be mutually exclusive or co-exist in the same protein molecule. 5) Indeed, O-GlcNAc and phosphorylation on some serine/threonine residues of Sp1 are likely to occur reciprocally. 32) Since Sp1 phosphorylation affects Sp1 DNA binding and transactivation, the precise relationship between O-GlcNAc and O-phosphate in Sp1 and their effects on Sp1 DNA binding should be determined. Furthermore, Oct1 and Elf-1 are also O-GlcNAcylated, but the OGlcNAc effect on Oct1 and Elf-1 activities remains largely unknown. 33, 34) The presence of O-GlcNAc in these proteins might affect their stability, interactions with their co-regulatory proteins, or binding to their cognate DNA sequences. The relationship between OGlcNAc and O-phosphate on Elf-1 and Oct1 should be determined as well. However, all these complicated aspects are assessable only if the O-GlcNAc and phosphorylation sites on these proteins are completely defined and site-directed mutants devoid of the various modifications are available. Recent studies strongly indicate that O-GlcNAcylation inhibits transcription, although there are also reports that elevated O-GlcNAc increases Sp1-activated transcription. 35) O-GlcNAcylation of Sp1 and CREB inhibits their interactions with TAFII130, a component of TFIID of the RNA polymerase II basal transcription machinery, implying that O-GlcNAc suppresses Sp1-or CREBmediated basal transcription. 12, 20, 24) Cooperative and synergistic activation of gene transcription by different transcription factors is the central theme in gene regulation in eukaryotic organisms. 36, 37) The molecular mechanism of transcriptional cooperativity is the stabilized DNA binding of different transcription factors through physical interactions among proteins, and this provides various regulatory advantages, such as integrated control of different signals. 36, 37) Sp1 has a variety of cooperative partners, but O-GlcNAc in the second transactivation domain of Sp1 inhibits physical interactions between Sp1 and its cooperating factors. [21] [22] [23] 38) Furthermore, O-GlcNAcylation of proteins bound to chromatin appears to be important to gene-specific and promoter-specific repression of transcription, given that Drosophila polytene chromosome contains a large amount of O-GlcNAc-bearing proteins, but less around transcriptionally active regions, 39) O-GlcNAc cycling is active in the promoters of Caenorhabditis elegans genes, 40) OGT is recruited to promoters by participating in corepressor complexes, 15) and OGT is an essential component of the Polycomb complex in transcription repression. 25) These findings of dynamic O-GlcNAc cycling in promoters highlight the active roles of OGlcNAc in the transcription process in the context of chromatin.
O-GlcNAcylation is a common protein modification found in transcription regulatory proteins and is comparable to phosphorylation. Since phosphorylation significantly affects the DNA binding of transcription factors and thus regulates their transcription capabilities, 16, 41) a possible connection between the O-GlcNAc of transcription factors and their DNA binding has been proposed. 1) However, whether O-GlcNAcylation of transcription factors affects their binding to promoters in vivo remains undetermined. Jackson and Tjian biochemically investigated O-GlcNAc effects on Sp1 DNA binding activity, but found no difference between unmodified and O-GlcNAcylated Sp1 species in DNA binding. 3) We and others have reported biochemical evidence that OGlcNAc interrupts protein-protein interactions between Sp1 and cooperative proteins. 12, [21] [22] [23] In conjunction with these results, the present study suggests the possibility that O-GlcNAc of Sp1 affects Sp1 binding to its cognate DNA sequence not by altering Sp1 DNA binding activity but by restricting the functional complex formation of Sp1 and its collaborating partner proteins on specific promoter regulatory elements, where Sp1 and its partners bind essentially in a cooperative manner.
